What’s going on?
- Moderna said it tested the vaccine on 10 adults who were between 56 and 70 years old, as well as 10 elderly adults who were 71 and older, according to CNBC.
- These participants received two 100 microgram doses of the vaccine within a 28-day span.
- The vaccine reportedly added antibodies into the patients’ symptoms, which could be necessary to stop the novel coronavirus, according to CNBC.
- Patients reportedly felt fatigue, chills, headaches and pain where they were injected. The symptoms resolved in two days.
- Unsurprisingly, Modern shares jumped 6% in trading on Wednesday.
- “Now we are really going at full speed.”
Health officials hope there will be a COVID-19 vaccine by the end of the year, according to WBUR. There have been no guarantees from scientists.